1. Oral Solid Tablet
  2. Recombinant Protein

Production Platforms

Zelgen has built up its commercial GMP manufacturing facilities for oral solid tablet preparations (11,000 square meters) and recombinant biologics (4,000 square meters), with ancillary facilities of power supply and sewage treatment systems. The comprehensive GMP system is under development. These facilities in compliance with cGMP guidelines provide Zelgen with more flexible manufacturing capacity, cost effectiveness and competitive advantages.